Drug Launch

Stocks

Natco Pharma Launched a Generic Version of Celgene’s Pomalyst in US
Byaea2ede5_admin March 3, 2026

March 3, 2026March 3, 2026 Natco Pharma Ltd said on Tuesday, 3 March, that it and its partner Breckenridge Pharmaceutical have introduced Pomalidomide capsules, a generic version of Celgene’s Pomalyst, in the United States. The capsules, a thalidomide analogue, are indicated for the treatment of adult patients with multiple…

Read More Natco Pharma Launched a Generic Version of Celgene’s Pomalyst in US
Stocks

Glenmark Pharma Shares Slump 1% Despite US Arm Launches Injection – Equitypandit
Byaea2ede5_admin February 27, 2025

February 27, 2025February 27, 2025 Shares of Glenmark Pharmaceuticals Ltd were trading in the red and 1% lower on Thursday, 27 February, despite the company’s US-based subsidiary announcing launching its epinephrine injection USP, a medication used to treat severe allergic responses. An injection comprising 10 mg/10 mL (1 mg/mL)…

Read More Glenmark Pharma Shares Slump 1% Despite US Arm Launches Injection – Equitypandit